Document is current
Any future updates will be listed below
-
Authors
Luigetti, Marco https://orcid.org/0000-0001-7539-505X
Di Paolantonio, Andrea
Guglielmino, Valeria
Romano, Angela
-
Funding
Funding for this research was provided by:
Pfizer
- License Information
-
More Information
Article History
Received: 8 July 2022
Accepted: 2 August 2022
First Online: 9 August 2022
Declarations
:
: We confirm that we have read the journal’s position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.
: Dr Luigetti received financial grants (honoraria and speaking) from Akcea, Alnylam, Sobi, and Pfizer and travel grants from Akcea, Alnylam, Sobi, Pfizer, Kedrion, Csl Behring, and Grifols; Dr Di Paolantonio received financial grants (honoraria and speaking) from Akcea, Alnylam, and Sobi and travel grants from Akcea; Dr Guglielmino reported no disclosures; and Dr Romano received financial grants (honoraria and speaking) from Akcea and travel grants from Akcea, Alnylam, Pfizer, and Csl Behring.
